{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:09:37Z","timestamp":1792030177752,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ajog.2007.10.793","type":"journal-article","created":{"date-parts":[[2008,1,28]],"date-time":"2008-01-28T07:09:12Z","timestamp":1201504152000},"page":"385.e1-385.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia"],"prefix":"10.1016","volume":"198","author":[{"given":"Anne M.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Giclas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2007.10.793_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jri.2007.03.015","article-title":"Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update","volume":"76","author":"Dekker","year":"2007","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1081\/PRG-120021066","article-title":"Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States","volume":"22","author":"Zhang","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2007.10.793_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1016248","article-title":"Endothelial dysfunction in preeclampsia","volume":"16","author":"Roberts","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ajog.2007.10.793_bib4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)62567-9","article-title":"Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome","volume":"160","author":"Zhou","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2007.10.793_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2007.10.793_bib6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajog.2005.10.192","article-title":"Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women","volume":"194","author":"Levine","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2007.10.793_bib7","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.placenta.2006.11.008","article-title":"How does the maternal immune system contribute to the development of pre-eclampsia?","volume":"28","author":"Moffett","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2007.10.793_bib8","series-title":"Principles and practive of clinical immunology","article-title":"Complement","author":"Holers","year":"2001"},{"key":"10.1016\/j.ajog.2007.10.793_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000087963","article-title":"The complement system at the fetomaternal interface","volume":"89","author":"Bulla","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.ajog.2007.10.793_bib10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2007.10.793_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib12","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2005"},{"key":"10.1016\/j.ajog.2007.10.793_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajog.2007.10.793_bib14","doi-asserted-by":"crossref","first-page":"ii46","DOI":"10.1136\/ard.61.suppl_2.ii46","article-title":"Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis","volume":"61","author":"Salmon","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajog.2007.10.793_bib15","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2007.10.793_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molimm.2004.07.043","article-title":"A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice","volume":"42","author":"Thurman","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib17","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajog.2007.10.793_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1074-7613(03)00321-2","article-title":"Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway","volume":"19","author":"Mao","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.ajog.2007.10.793_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2007.10.793_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1542\/peds.37.3.403","article-title":"Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks","volume":"37","author":"Lubchenco","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2007.10.793_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ajog.2005.10.813","article-title":"Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?","volume":"194","author":"Villar","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.10.793_bib22","first-page":"19","article-title":"Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"79","author":"Haeger","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.10.793_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-0378(02)00039-6","article-title":"The partner\u2019s role in the etiology of preeclampsia","volume":"57","author":"Dekker","year":"2002","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2007.10.793_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.287.5452.498","article-title":"A critical role for murine complement regulator crry in fetomaternal tolerance","volume":"287","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ajog.2007.10.793_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4049\/jimmunol.122.1.146","article-title":"In vitro activation of complement by isolated human heart subcellular membranes","volume":"122","author":"Giclas","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2007.10.793_bib28","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","article-title":"Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles","volume":"178","author":"Germain","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0950-3552(05)80005-7","article-title":"Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship","volume":"6","author":"Holmes","year":"1992","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2007.10.793_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1521-6616(03)00034-2","article-title":"The complement system as a therapeutic target in autoimmunity","volume":"107","author":"Holers","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajog.2007.10.793_bib31","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937807020157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937807020157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:25:18Z","timestamp":1757586318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937807020157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0002937807020157"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2007.10.793","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2007.10.793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}